How to Estimate the Minimal Clinically Important Difference: An Overview

Area of Science:

• Health outcomes research
• Clinical trial methodology

Background:

• The minimal clinically important difference (MCID) is crucial for interpreting changes in patient-reported outcome measures (PROMs).
• It represents a threshold for patient-perceived symptom changes, vital for population-level analysis.
• High variability in MCID estimates is a significant limitation due to the absence of a gold standard methodology.

Purpose of the Study:

• To address the variability in MCID estimation.
• To propose a strategy for robust MCID determination.
• To ensure both patient-relevance and statistical validity in PROM interpretation.

Main Methods:

• Review of existing MCID methodologies.
• Comparison of anchor-based and distribution-based approaches.
• Synthesis of strategies for improved MCID estimation.

Main Results:

• MCID estimation is characterized by high variability.
• Anchor-based methods capture patient-perceived relevance.
• Distribution-based methods provide statistical significance.

Conclusions:

• Reporting both anchor-based and distribution-based MCID estimates is recommended.
• This dual approach enhances the clinical relevance and statistical validity of PROM changes.
• This strategy improves the interpretation of PROMs at a population level.